CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Consensus from the 5th European Bifurcation Club meeting From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) Cost-Effectiveness of Different Durations of Dual-Antiplatelet Use After Percutaneous Coronary Intervention Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus Timing of intervention in asymptomatic patients with valvular heart disease Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF Prevalence and clinical implications of valvular calcification on coronary computed tomography angiography Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure Optical Frequency Domain Imaging Versus Intravascular Ultrasound in Percutaneous Coronary Intervention (OPINION Trial) Results From the OPINION Imaging Study DAPT, Our Genome and Clopidogrel

JOURNAL:CBS2017 Article Link

CBS exhibits at EuroPCR 2017 in Paris

CBS2017

Paris, France - Starting from May 16, Left Main & Coronary Bifurcation Summit (CBS) will present the next congress plan at EuroPCR 2017 in Paris. An on-site platform for treatment against left main and coronary bifurcation lesions will be located on the third floor of the Palais des Congrès. All participants and cardiovascular experts are welcomed to CBS booth stand H9 during this 4-day meeting.

On the 10th Summit in this winter, CBS will continue the concept of patient-centric care. Discussion on the objectives like applying big data with well designed RCT to obtain more clinical evidence, incorporation of new interventional technologies and treatment options, integration of hemodynamic evaluation and mechanisms into the treatment, analysis and comparison of treatment options will be put on extra weight. CBS2017 will be helpful to make a comprehensive and in-depth academic exploration on the issue of left main and coronary bifurcation disease.